These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26846446)

  • 1. Effectiveness of Pharmacist-Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review.
    Dixon DL; Dunn SP; Kelly MS; McLlarky TR; Brown RE
    Pharmacotherapy; 2016 Feb; 36(2):230-6. PubMed ID: 26846446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
    Snider M; Kalbfleisch S; Carnes CA
    Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacist-managed amiodarone monitoring program.
    Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
    J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone for the management of atrial fibrillation.
    Brenner R; Delacrétaz E
    Swiss Med Wkly; 2011; 141():w13158. PubMed ID: 21370206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice.
    Lifer SM; Musser MR; Kier KL
    J Am Pharm Assoc (2003); 2015; 55(5):546-51. PubMed ID: 26208334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation.
    Khan MH; Rochlani Y; Aronow WS
    Expert Opin Drug Saf; 2017 Dec; 16(12):1407-1412. PubMed ID: 28960089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy.
    Rankin S; Elder DH; Ogston S; George J; Lang CC; Choy AM
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28276175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Adverse Event Monitoring in Ambulatory Patients on Amiodarone or Dofetilide.
    Rickard JP; Negrelli J; Olson JL; Dick T
    J Pharm Pract; 2018 Oct; 31(5):457-461. PubMed ID: 28884613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia caused by amiodarone in older people.
    Hindle JV; Ibrahim A; Ramaraj R
    Age Ageing; 2008 May; 37(3):347-8. PubMed ID: 18385185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist.
    Johnson SG
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S19-25. PubMed ID: 19678723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction.
    Huang CJ; Tseng CL; Chu CH; Huang DF; Huang CC; Lin LY
    J Eval Clin Pract; 2017 Feb; 23(1):108-113. PubMed ID: 27515316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone and dronedarone: An update.
    Vamos M; Hohnloser SH
    Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.